Adherence to a Lifestyle Monitoring System in Patients with Heart Disease

Adherence to a Lifestyle Monitoring System in Patients with Heart Disease - Care-On

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50694

Enrollment

100

Registered

2021-10-08

Start date

2021-11-08

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease and atrial fibrillation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients selected for or that underwent coronary artery bypass surgery (CABG), an electrophysiological test (EFO) and/orradiofrequency catheter ablation (RFCA), a transcatheter aortic valve implantation (TAVI), a fractional flow reservetest (FFR) and/or a percutaneous coronary intervention (PCI), and/or valve surgery. - Age >= 18 years. - Able to speak and read the Dutch language. - Willing and able to provide informed consent.

Exclusion criteria

Exclusion criteria: - No internet connection at home. - Not in possession of a computer or tablet, and mobile phone. - Not able or willing to wear activity tracker on a daily basis (for example due to work related obligations). - Major planned (cardiac) surgery in the upcoming 3 months. - Life expectancy

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the adherence (i.e., the % of participants still using a patient-centred lifestyle monitoring system at 1-year follow-up).	—

Secondary

Measure	Time frame
The secondary endpoints are: - Usability will be measured using the System Usability Scale (SUS) score and success rate. - To measure the correlation of demographic and disease characteristics, quality of life, self-efficacy, depressive symptoms, anxiety, motivation, stage of change, fatigue, physical fitness, levels of metal stress, use of a goal tracking functionality, use of the sharing functionality with external contacts, perception of system usability and prior experience with technology with adherence. Standardized questionnaires will be used for self-report measures and objective ambulatory measures from the lifestyle monitoring system for objective lifestyle measures. - The association between adherence with clinical outcomes will be examined by evaluation patient clinical records (clinical events) and standardized self-report data (quality of life).	—

Measure

Time frame

The secondary endpoints are: - Usability will be measured using the System Usability Scale (SUS) score and success rate. - To measure the correlation of demographic and disease characteristics, quality of life, self-efficacy, depressive symptoms, anxiety, motivation, stage of change, fatigue, physical fitness, levels of metal stress, use of a goal tracking functionality, use of the sharing functionality with external contacts, perception of system usability and prior experience with technology with adherence. Standardized questionnaires will be used for self-report measures and objective ambulatory measures from the lifestyle monitoring system for objective lifestyle measures. - The association between adherence with clinical outcomes will be examined by evaluation patient clinical records (clinical events) and standardized self-report data (quality of life).

—

Countries

Netherlands

Outcome results